Research news
Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.
UK researchers publish further evidence highlighting the need to licence pimavanserin for hallucinations and delusions in Parkinson's.
New research suggests that a type of asthma drug that activates a protein called beta-adrenoceptors, may decrease risk of Parkinson's.
New research, reported in the scientific journal Nature, suggests that the immune system plays an important role in the progression of Parkinson's.
Higher consumption of low fat dairy products such as milk, butter, cheese and yoghurt is linked to a modest increase in risk of Parkinson’s, according to new research.
New research published in Nature Biotechnology shows that it may be possible to reprogramme cells inside the brain to reverse the symptoms of Parkinson's.
Results from a clinical trial suggest an inhalable form of levodopa could help people with Parkinson's who experience 'off periods'.
A research team at Imperial College are testing the use of high-intensity, focused ultrasound waves for the first time in the UK to treat tremor.
Research funded by Parkinson's UK has found MRIs, a type of brain scan, to be 'highly accurate' at identifying mild to moderate Parkinson's.
An abnormal protein normally found in brain cells affected in Parkinson's can move from the gut to the brain, according to new research.